Journal
CIRCULATION
Volume 139, Issue 12, Pages E553-E578Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIR.0000000000000598
Keywords
AHA Scientific Statements; antibodies; heart transplantation; human leukocyte antigen
Ask authors/readers for more resources
Sensitization, defined as the presence of circulating antibodies, presents challenges for heart transplant recipients and physicians. When present, sensitization can limit a transplantation candidate's access to organs, prolong wait time, and, in some cases, exclude the candidate from heart transplantation altogether. The management of sensitization is not yet standardized, and current therapies have not yielded consistent results. Although current strategies involve antibody suppression and removal with intravenous immunoglobulin, plasmapheresis, and antibody therapy, newer strategies with more specific targets are being investigated.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available